Rapid Application of Infliximab. Efficacy and Complications
Infliximab en infusión intravenosa rápida. Eficacia y complicaciones
David Bañuelos-Ramíreza,
, María Magdalena Ramírez-Palmab, María Elena Balcázar-Sánchezc, Silvia Sánchez-Alonsoa
a Hospital de Especialidades UMAE, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, IMSS, Puebla, México
b Unidad de Medicina Familiar núm. 1, IMSS, Puebla, México
c Consulta Especializada de Reumatología, Hospital de Especialidades UMAE, Centro Médico Nacional Gral. de Div. Manuel Ávila Camacho, IMSS, Puebla, México
Leído
5264
Vecesse ha leído el artículo
2598
Total PDF
2666
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 0 | 2 | 2 |
| 2025 5 | 65 | 51 | 116 |
| 2025 4 | 53 | 26 | 79 |
| 2025 3 | 42 | 31 | 73 |
| 2025 2 | 49 | 27 | 76 |
| 2025 1 | 32 | 62 | 94 |
| 2024 12 | 15 | 27 | 42 |
| 2024 11 | 40 | 75 | 115 |
| 2024 10 | 28 | 51 | 79 |
| 2024 9 | 31 | 24 | 55 |
| 2024 8 | 43 | 41 | 84 |
| 2024 7 | 30 | 30 | 60 |
| 2024 6 | 29 | 30 | 59 |
| 2024 5 | 30 | 35 | 65 |
| 2024 4 | 20 | 30 | 50 |
| 2024 3 | 38 | 29 | 67 |
| 2024 2 | 20 | 22 | 42 |
| 2024 1 | 16 | 22 | 38 |
| 2023 12 | 20 | 31 | 51 |
| 2023 11 | 17 | 26 | 43 |
| 2023 10 | 31 | 26 | 57 |
| 2023 9 | 40 | 35 | 75 |
| 2023 8 | 16 | 7 | 23 |
| 2023 7 | 14 | 20 | 34 |
| 2023 6 | 13 | 16 | 29 |
| 2023 5 | 15 | 11 | 26 |
| 2023 4 | 8 | 7 | 15 |
| 2023 3 | 17 | 28 | 45 |
| 2023 2 | 12 | 25 | 37 |
| 2022 1 | 9 | 21 | 30 |
| 2022 12 | 17 | 32 | 49 |
| 2022 11 | 17 | 27 | 44 |
| 2022 10 | 18 | 19 | 37 |
| 2022 9 | 22 | 33 | 55 |
| 2022 8 | 10 | 44 | 54 |
| 2022 7 | 16 | 36 | 52 |
| 2022 6 | 18 | 36 | 54 |
| 2022 5 | 14 | 39 | 53 |
| 2022 4 | 19 | 38 | 57 |
| 2022 3 | 20 | 41 | 61 |
| 2022 2 | 14 | 34 | 48 |
| 2021 1 | 20 | 35 | 55 |
| 2021 12 | 13 | 44 | 57 |
| 2021 11 | 20 | 48 | 68 |
| 2021 10 | 16 | 44 | 60 |
| 2021 9 | 15 | 44 | 59 |
| 2021 8 | 16 | 45 | 61 |
| 2021 7 | 15 | 28 | 43 |
| 2021 6 | 17 | 42 | 59 |
| 2021 5 | 15 | 37 | 52 |
| 2021 4 | 32 | 36 | 68 |
| 2021 3 | 25 | 30 | 55 |
| 2021 2 | 20 | 16 | 36 |
| 2020 1 | 9 | 16 | 25 |
| 2020 12 | 19 | 20 | 39 |
| 2020 11 | 10 | 21 | 31 |
| 2020 10 | 11 | 5 | 16 |
| 2020 9 | 15 | 13 | 28 |
| 2020 8 | 9 | 12 | 21 |
| 2020 7 | 5 | 21 | 26 |
| 2020 6 | 22 | 21 | 43 |
| 2020 5 | 22 | 10 | 32 |
| 2020 4 | 8 | 13 | 21 |
| 2020 3 | 11 | 10 | 21 |
| 2018 12 | 3 | 0 | 3 |
| 2018 5 | 4 | 3 | 7 |
| 2018 4 | 17 | 15 | 32 |
| 2018 3 | 29 | 20 | 49 |
| 2018 2 | 15 | 6 | 21 |
| 2018 1 | 14 | 11 | 25 |
| 2017 12 | 7 | 8 | 15 |
| 2017 11 | 11 | 12 | 23 |
| 2017 10 | 8 | 11 | 19 |
| 2017 9 | 10 | 8 | 18 |
| 2017 8 | 6 | 12 | 18 |
| 2017 7 | 9 | 11 | 20 |
| 2017 6 | 24 | 8 | 32 |
| 2017 5 | 14 | 15 | 29 |
| 2017 4 | 14 | 13 | 27 |
| 2017 3 | 22 | 6 | 28 |
| 2017 2 | 6 | 4 | 10 |
| 2016 1 | 13 | 5 | 18 |
| 2016 12 | 29 | 12 | 41 |
| 2016 11 | 10 | 1 | 11 |
| 2016 10 | 22 | 9 | 31 |
| 2016 9 | 23 | 3 | 26 |
| 2016 8 | 20 | 5 | 25 |
| 2016 7 | 12 | 4 | 16 |
| 2016 4 | 1 | 0 | 1 |
| 2015 12 | 2 | 0 | 2 |
| 2015 9 | 3 | 0 | 3 |
| 2015 8 | 1 | 0 | 1 |
| 2015 7 | 11 | 5 | 16 |
| 2015 6 | 19 | 10 | 29 |
| 2015 5 | 27 | 18 | 45 |
| 2015 4 | 19 | 15 | 34 |
| 2015 3 | 15 | 11 | 26 |
| 2015 2 | 23 | 17 | 40 |
| 2015 1 | 9 | 15 | 24 |
| 2014 12 | 20 | 17 | 37 |
| 2014 11 | 11 | 15 | 26 |
| 2014 10 | 17 | 16 | 33 |
| 2014 9 | 9 | 9 | 18 |
| 2014 8 | 18 | 24 | 42 |
| 2014 7 | 20 | 25 | 45 |
| 2014 6 | 35 | 26 | 61 |
| 2014 5 | 31 | 35 | 66 |
| 2014 4 | 33 | 12 | 45 |
| 2014 3 | 33 | 19 | 52 |
| 2014 2 | 33 | 7 | 40 |
| 2014 1 | 29 | 31 | 60 |
| 2013 12 | 26 | 8 | 34 |
| 2013 11 | 13 | 10 | 23 |
| 2013 10 | 38 | 11 | 49 |
| 2013 9 | 24 | 19 | 43 |
| 2013 8 | 35 | 17 | 52 |
| 2013 7 | 19 | 14 | 33 |
| 2013 6 | 36 | 16 | 52 |
| 2013 5 | 25 | 17 | 42 |
| 2013 4 | 26 | 17 | 43 |
| 2013 3 | 21 | 11 | 32 |
| 2013 2 | 25 | 14 | 39 |
| 2013 1 | 25 | 20 | 45 |
| 2012 12 | 18 | 18 | 36 |
| 2012 11 | 13 | 8 | 21 |
| 2012 10 | 3 | 6 | 9 |
| 2012 9 | 10 | 5 | 15 |
| 2012 5 | 3 | 0 | 3 |
| 2012 4 | 2 | 0 | 2 |
| 2012 3 | 5 | 0 | 5 |
| 2012 2 | 2 | 0 | 2 |
| 2011 1 | 5 | 0 | 5 |
| 2011 12 | 3 | 0 | 3 |
| 2011 11 | 4 | 0 | 4 |
| 2011 10 | 3 | 0 | 3 |
| 2011 9 | 2 | 0 | 2 |
| 2011 8 | 2 | 0 | 2 |
| 2011 7 | 3 | 0 | 3 |
| 2011 6 | 2 | 0 | 2 |
| 2011 5 | 2 | 0 | 2 |
| 2011 3 | 3 | 0 | 3 |
| 2011 2 | 4 | 0 | 4 |
| 2010 1 | 4 | 0 | 4 |
| 2010 12 | 4 | 0 | 4 |
| 2010 11 | 4 | 0 | 4 |
| 2010 10 | 5 | 0 | 5 |
| 2010 9 | 4 | 0 | 4 |
| 2010 8 | 7 | 0 | 7 |
| 2010 7 | 3 | 0 | 3 |
| 2010 6 | 4 | 0 | 4 |
| 2010 5 | 5 | 0 | 5 |
| 2010 4 | 10 | 0 | 10 |
| 2010 3 | 4 | 0 | 4 |
| 2010 2 | 6 | 0 | 6 |
| 2009 1 | 23 | 0 | 23 |
| 2009 12 | 11 | 0 | 11 |
| 2009 11 | 7 | 0 | 7 |
| 2009 10 | 5 | 0 | 5 |
| 2009 9 | 2 | 0 | 2 |
| 2009 8 | 9 | 0 | 9 |
| 2009 7 | 2 | 0 | 2 |
| 2009 6 | 13 | 0 | 13 |
| 2009 5 | 10 | 0 | 10 |
| 2009 4 | 13 | 0 | 13 |
| 2009 3 | 5 | 0 | 5 |
Mostrar todo
